Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors

References

• Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A, . Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys 2007;68:370–6.
   Google Scholar
• Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg 2007;137:130–7.
   PubMed Web of Science ®Google Scholar
• Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M, . [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 2006;6:51.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Rajendran J, Yueh B, Coltrera MD, Leblanc M, Eary J, . FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 2004;130:1361–7.
   PubMedGoogle Scholar
• Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, . Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20: 1398–404.
   PubMed Web of Science ®Google Scholar
• Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004;59:1295–300.
   PubMed Web of Science ®Google Scholar
• Roh JL, Pae KH, Choi SH, Kim JS, Lee S, Kim SB, . 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol 2007;33:790–5.
   PubMedGoogle Scholar
• Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56–68.
   PubMed Web of Science ®Google Scholar
• Davies A, Tan C, Paschalides C, Barrington SF, O'Doherty M, Utley M, . FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer 2007;55:75–8.
   PubMed Web of Science ®Google Scholar
• Kim SY, Roh JL, Kim MR, Kim JS, Choi SH, Nam SY, . Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 2007;48:752–7.
   PubMed Web of Science ®Google Scholar
• Abramyuk A, Tokalov S, Zophel K, Koch A, Szluha Lazanyi K, Gillham C, . Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 2009;91:399–404.
   PubMed Web of Science ®Google Scholar
• Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. Am J Neuroradiol 2005;26:1178–85.
   PubMed Web of Science ®Google Scholar
• Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji SK. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? Am J Neuroradiol 2007;28:328–34.
   Google Scholar
• Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ishikura H. Pathophysiology of tumor neovascularization. Vasc Health Risk Manag 2005;1:277–90.
   PubMedGoogle Scholar
• Brown JM. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 2002;1:453–8.
   PubMed Web of Science ®Google Scholar
• Moulder JE, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 1984;10: 695–712.
   PubMed Web of Science ®Google Scholar
• Plotnick RE, Gardner RH, Hargrove WW, Prestegaard K, Perlmutter M. Lacunarity analysis: a general technique for the analysis of spatial patterns. Phys Rev E 1996;53: 5461–8.
   PubMed Web of Science ®Google Scholar
• Smith TG Jr, Lange GD, Marks WB. Fractal methods and results in cellular morphology – dimensions, lacunarity and multifractals. J Neurosci Methods 1996;69:123–36.
   PubMed Web of Science ®Google Scholar
• Rasband WS. ImageJ, version 1.41o, US National Institutes of Health, Bethesda, USA, 1997–2008 (http://rsb.info.nih.gov/ij/).
   Google Scholar
• Karperien A. FracLac for ImageJ, version 2.5, 1999–2007 (http://rsb.info.nih.gov/ij/plugins/fraclac/FLHelp/Introduction.htm).
   Google Scholar
• de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, . Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79–87.
   PubMed Web of Science ®Google Scholar
• Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, . Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003;97:1015–24.
   PubMed Web of Science ®Google Scholar
• Hara T, Bansal A, DeGrado TR. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells. Nucl Med Biol 2006;33:977–84.
   PubMed Web of Science ®Google Scholar
• Schutze C, Bergmann R, Yaromina A, Hessel F, Kotzerke J, Steinbach J, . Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol 2007; 83:311–15.
   PubMed Web of Science ®Google Scholar
• Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, . Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 2007;13:3255–63.
   Google Scholar
• Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, . Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. Am J Roentgenol 2009;192:W156–60.
   Google Scholar
• Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–6.
   PubMed Web of Science ®Google Scholar
• Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, Sigal R, . Oxygenation of head and neck tumors. Cancer 1993;71:2319–25.
   PubMed Web of Science ®Google Scholar
• Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004;14:198–206.
   PubMed Web of Science ®Google Scholar
• Cao M, Liang Y, Shen C, Miller K, Stantz K. Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype. IEEE Trans Med Imaging 2009;28:861–71.
   PubMed Web of Science ®Google Scholar
• Bisdas S, Spicer K, Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. Am J Neuroradiol 2008;29:1376–81.
   Google Scholar
• Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:22–8.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Holzner F, Paulsen F, Alber M. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol 2006;80:151–6.
   PubMed Web of Science ®Google Scholar
• Warburg O. On respiratory impairment in cancer cells. Science 1956;124:269–70.
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P. Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int J Cancer 1989;44:266–72.
   PubMed Web of Science ®Google Scholar